| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.007 |